Inhibition of the tumor necrosis factor-α pathway is radioprotective for the lung

Ming Zhang, Jun Qian, Xianying Xing, Feng Ming Kong, Lujun Zhao, Ming Chen, Theodore S. Lawrence

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Purpose: Radiation-induced lung toxicity limits the delivery of high-dose radiation to thoracic tumors. Here, we investigated the potential of inhibiting the tumor necrosis factor-α (TNF-α) pathway as a novel radioprotection strategy. Experimental Design: Mouse lungs were irradiated with various doses and assessed at varying times for TNF-α production. Lung toxicity was measured by apoptosis and pulmonary function testing. TNF receptor1 (TNFR1) inhibition, achieved by genetic knockout or antisense oligonucleotide (ASO) silencing, was tested for selective lung protection in a mouse lung metastasis model of colon cancer. Results: Lung radiation induced local production of TNF-α by macrophages in BALB/cmice 3 to 24 hours after radiation (15 Gy). A similar maximal induction was found 1week after the start of radiation when 15 Gy was divided into five daily fractions. Cell apoptosis in the lung, measured by terminal deoxyribonucleotide transferase - mediated nick-end labeling staining (mostly epithelial cells) and Western blot for caspase-3, was induced by radiation in a dose- and time-dependent manner. Specific ASO inhibited lung TNFR1 expression and reduced radiation-induced apoptosis. Radiation decreased lung function in BALB/c and C57BL mice 4 to 8 weeks after completion of fractionated radiation (40 Gy). Inhibition of TNFR1 by genetic deficiency (C57BL mice) or therapeutic silencing with ASO (BALB/c mice) tended to preserve lung function without compromising lung tumor sensitivity to radiation. Conclusion: Radiation-induced lung TNF-α production correlates with early cell apoptosis and latent lung function damage. Inhibition of lung TNFR1is selectively radioprotective for the lung without compromising tumor response. These findings support the development of a novel radioprotection strategy using inhibition of the TNF-α pathway.

Original languageEnglish (US)
Pages (from-to)1868-1876
Number of pages9
JournalClinical Cancer Research
Volume14
Issue number6
DOIs
StatePublished - Mar 15 2008

Fingerprint

Tumor Necrosis Factor-alpha
Lung
Radiation
Antisense Oligonucleotides
Apoptosis
Radiation Dosage
Inbred C57BL Mouse
Deoxyribonucleotides
Neoplasms
Radiation Tolerance
Transferases
Caspase 3
Colonic Neoplasms
Research Design
Thorax
Western Blotting
Epithelial Cells
Macrophages
Staining and Labeling
Neoplasm Metastasis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Zhang, M., Qian, J., Xing, X., Kong, F. M., Zhao, L., Chen, M., & Lawrence, T. S. (2008). Inhibition of the tumor necrosis factor-α pathway is radioprotective for the lung. Clinical Cancer Research, 14(6), 1868-1876. https://doi.org/10.1158/1078-0432.CCR-07-1894

Inhibition of the tumor necrosis factor-α pathway is radioprotective for the lung. / Zhang, Ming; Qian, Jun; Xing, Xianying; Kong, Feng Ming; Zhao, Lujun; Chen, Ming; Lawrence, Theodore S.

In: Clinical Cancer Research, Vol. 14, No. 6, 15.03.2008, p. 1868-1876.

Research output: Contribution to journalArticle

Zhang, M, Qian, J, Xing, X, Kong, FM, Zhao, L, Chen, M & Lawrence, TS 2008, 'Inhibition of the tumor necrosis factor-α pathway is radioprotective for the lung', Clinical Cancer Research, vol. 14, no. 6, pp. 1868-1876. https://doi.org/10.1158/1078-0432.CCR-07-1894
Zhang, Ming ; Qian, Jun ; Xing, Xianying ; Kong, Feng Ming ; Zhao, Lujun ; Chen, Ming ; Lawrence, Theodore S. / Inhibition of the tumor necrosis factor-α pathway is radioprotective for the lung. In: Clinical Cancer Research. 2008 ; Vol. 14, No. 6. pp. 1868-1876.
@article{20d71a499e9a4f9986d971c1b511db79,
title = "Inhibition of the tumor necrosis factor-α pathway is radioprotective for the lung",
abstract = "Purpose: Radiation-induced lung toxicity limits the delivery of high-dose radiation to thoracic tumors. Here, we investigated the potential of inhibiting the tumor necrosis factor-α (TNF-α) pathway as a novel radioprotection strategy. Experimental Design: Mouse lungs were irradiated with various doses and assessed at varying times for TNF-α production. Lung toxicity was measured by apoptosis and pulmonary function testing. TNF receptor1 (TNFR1) inhibition, achieved by genetic knockout or antisense oligonucleotide (ASO) silencing, was tested for selective lung protection in a mouse lung metastasis model of colon cancer. Results: Lung radiation induced local production of TNF-α by macrophages in BALB/cmice 3 to 24 hours after radiation (15 Gy). A similar maximal induction was found 1week after the start of radiation when 15 Gy was divided into five daily fractions. Cell apoptosis in the lung, measured by terminal deoxyribonucleotide transferase - mediated nick-end labeling staining (mostly epithelial cells) and Western blot for caspase-3, was induced by radiation in a dose- and time-dependent manner. Specific ASO inhibited lung TNFR1 expression and reduced radiation-induced apoptosis. Radiation decreased lung function in BALB/c and C57BL mice 4 to 8 weeks after completion of fractionated radiation (40 Gy). Inhibition of TNFR1 by genetic deficiency (C57BL mice) or therapeutic silencing with ASO (BALB/c mice) tended to preserve lung function without compromising lung tumor sensitivity to radiation. Conclusion: Radiation-induced lung TNF-α production correlates with early cell apoptosis and latent lung function damage. Inhibition of lung TNFR1is selectively radioprotective for the lung without compromising tumor response. These findings support the development of a novel radioprotection strategy using inhibition of the TNF-α pathway.",
author = "Ming Zhang and Jun Qian and Xianying Xing and Kong, {Feng Ming} and Lujun Zhao and Ming Chen and Lawrence, {Theodore S.}",
year = "2008",
month = "3",
day = "15",
doi = "10.1158/1078-0432.CCR-07-1894",
language = "English (US)",
volume = "14",
pages = "1868--1876",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "6",

}

TY - JOUR

T1 - Inhibition of the tumor necrosis factor-α pathway is radioprotective for the lung

AU - Zhang, Ming

AU - Qian, Jun

AU - Xing, Xianying

AU - Kong, Feng Ming

AU - Zhao, Lujun

AU - Chen, Ming

AU - Lawrence, Theodore S.

PY - 2008/3/15

Y1 - 2008/3/15

N2 - Purpose: Radiation-induced lung toxicity limits the delivery of high-dose radiation to thoracic tumors. Here, we investigated the potential of inhibiting the tumor necrosis factor-α (TNF-α) pathway as a novel radioprotection strategy. Experimental Design: Mouse lungs were irradiated with various doses and assessed at varying times for TNF-α production. Lung toxicity was measured by apoptosis and pulmonary function testing. TNF receptor1 (TNFR1) inhibition, achieved by genetic knockout or antisense oligonucleotide (ASO) silencing, was tested for selective lung protection in a mouse lung metastasis model of colon cancer. Results: Lung radiation induced local production of TNF-α by macrophages in BALB/cmice 3 to 24 hours after radiation (15 Gy). A similar maximal induction was found 1week after the start of radiation when 15 Gy was divided into five daily fractions. Cell apoptosis in the lung, measured by terminal deoxyribonucleotide transferase - mediated nick-end labeling staining (mostly epithelial cells) and Western blot for caspase-3, was induced by radiation in a dose- and time-dependent manner. Specific ASO inhibited lung TNFR1 expression and reduced radiation-induced apoptosis. Radiation decreased lung function in BALB/c and C57BL mice 4 to 8 weeks after completion of fractionated radiation (40 Gy). Inhibition of TNFR1 by genetic deficiency (C57BL mice) or therapeutic silencing with ASO (BALB/c mice) tended to preserve lung function without compromising lung tumor sensitivity to radiation. Conclusion: Radiation-induced lung TNF-α production correlates with early cell apoptosis and latent lung function damage. Inhibition of lung TNFR1is selectively radioprotective for the lung without compromising tumor response. These findings support the development of a novel radioprotection strategy using inhibition of the TNF-α pathway.

AB - Purpose: Radiation-induced lung toxicity limits the delivery of high-dose radiation to thoracic tumors. Here, we investigated the potential of inhibiting the tumor necrosis factor-α (TNF-α) pathway as a novel radioprotection strategy. Experimental Design: Mouse lungs were irradiated with various doses and assessed at varying times for TNF-α production. Lung toxicity was measured by apoptosis and pulmonary function testing. TNF receptor1 (TNFR1) inhibition, achieved by genetic knockout or antisense oligonucleotide (ASO) silencing, was tested for selective lung protection in a mouse lung metastasis model of colon cancer. Results: Lung radiation induced local production of TNF-α by macrophages in BALB/cmice 3 to 24 hours after radiation (15 Gy). A similar maximal induction was found 1week after the start of radiation when 15 Gy was divided into five daily fractions. Cell apoptosis in the lung, measured by terminal deoxyribonucleotide transferase - mediated nick-end labeling staining (mostly epithelial cells) and Western blot for caspase-3, was induced by radiation in a dose- and time-dependent manner. Specific ASO inhibited lung TNFR1 expression and reduced radiation-induced apoptosis. Radiation decreased lung function in BALB/c and C57BL mice 4 to 8 weeks after completion of fractionated radiation (40 Gy). Inhibition of TNFR1 by genetic deficiency (C57BL mice) or therapeutic silencing with ASO (BALB/c mice) tended to preserve lung function without compromising lung tumor sensitivity to radiation. Conclusion: Radiation-induced lung TNF-α production correlates with early cell apoptosis and latent lung function damage. Inhibition of lung TNFR1is selectively radioprotective for the lung without compromising tumor response. These findings support the development of a novel radioprotection strategy using inhibition of the TNF-α pathway.

UR - http://www.scopus.com/inward/record.url?scp=41549108565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41549108565&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-07-1894

DO - 10.1158/1078-0432.CCR-07-1894

M3 - Article

C2 - 18347190

AN - SCOPUS:41549108565

VL - 14

SP - 1868

EP - 1876

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 6

ER -